Parkinson's Disease Trial, Not Yet Recruiting NCT06463769 Sponsor: University of Kiel Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06463769
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been identified as likely being in the early stage before Parkinson's disease fully develops, based on specific pre-set criteria.
  • People who have been diagnosed with Parkinson's disease at a mild to moderate level (rated between 1 and 2.5 on a standard disease severity scale called Hoehn & Yahr).
  • People whose usual diet is a Western-style diet, meaning at least 30% of their daily food energy comes from ultra-processed foods.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who currently follow a plant-based diet.
  • People who have food allergies or food intolerances.
  • People who have significant conditions affecting the digestive system (such as celiac disease), the brain or nervous system, or who have diabetes.
  • People who are underweight, meaning a body mass index (a measure of body weight relative to height) below 18.5.
  • People who currently smoke.
  • People whose medications are expected to change, or who are expected to need antibiotic treatment, during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anja Bosy-Westphal, PhD, MD, University of Kiel

Phone: +494318805674

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University of Kiel
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

abundance of key SCFA-producing gut bacteria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov